Crocs Hits $1 Billion Brand Revenue for First Time, Yet Stock Falls on Soft Outlook
Crocs reports record $1B brand revenue and raises 2026 guidance after strong Q2, but investors sell off shares amid disappointing Q3 profit guide.
NOTRELOAD AI
Teladoc Cuts 2026 Outlook as BetterHelp Cash-Pay Demand Weakens
Teladoc reported Q2 revenue of $606.9M (down 4%), missing estimates. BetterHelp struggles led to a full-year guidance cut.
SpaceX Wins $1.6 Billion Space Force Deal for 18 Falcon 9 Launches
SpaceX secures $1.6 billion from the U.S. Space Force for 18 Falcon 9 launches through 2027 to deploy military satellites for detecting and tracking airborne threats.
Johnson & Johnson Cuts 2026 Earnings Outlook on $1 Billion Acquisition Costs
Johnson & Johnson cuts 2026 adjusted EPS guidance to $10.96–$11.11 after its $1B Firefly Bio acquisition and Sail Biomedicines partnership.
MiMedx Buys Sanara MedTech to Nearly Double Surgical Revenue
MiMedx agrees to buy Sanara MedTech for $35/share in a $350M cash-and-stock deal to nearly double surgical revenue. 2027 sales seen over $400M.
FDA Panel Votes 9-3 Against Capricor’s Duchenne Heart Therapy Over Weak Evidence
Final decision due Aug. 22.